MedTrace Logo

Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings

NCT00897078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2013-06-13

No results posted yet for this study

Summary

RATIONALE: Gathering information about metabolic syndrome from young patients who have survived acute lymphoblastic leukemia (ALL) may help doctors learn more about the disease.

PURPOSE: This phase I trial is studying the metabolic syndrome in young patients who have survived acute lymphoblastic leukemia and in healthy sibling volunteers.

Conditions

Interventions

OTHER

laboratory biomarker analysis

OTHER

medical chart review

OTHER

metabolic assessment

OTHER

questionnaire administration

will be obtained at a single clinic visit

PROCEDURE

assessment of therapy complications

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Jill Simmons, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
8 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897078 on ClinicalTrials.gov